|Other Names||Zinc-alpha-2-glycoprotein, Zn-alpha-2-GP, Zn-alpha-2-glycoprotein, AZGP1, ZAG, ZNGP1|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP6628a was selected from the N-term region of human AZGP1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. May bind polyunsaturated fatty acids.|
|Tissue Location||Blood plasma, seminal plasma, urine, saliva, sweat, epithelial cells of various human glands, liver|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
AZGP1 stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. It may bind polyunsaturated fatty acids.
Yeung,D.C., J. Clin. Endocrinol. Metab. 94 (7), 2531-2536 (2009)Vanni,H., Chest 135 (5), 1197-1208 (2009)
If you have any additional inquiries please email technical services at email@example.com.